Peng Yu is a seasoned professional in the field of biologics analytical operations, currently serving as Senior Director at Gilead Sciences since December 2019, focusing on analytical control strategy and life cycle management. Prior to this role, Peng Yu held the position of Director at Halozyme, Inc. from January 2016 to December 2019, where responsibilities included biologics analytical development. A background in senior scientist roles at companies such as Allergan, Novartis, and Advanced Proteome Therapeutics Incorporated, coupled with a postdoctoral position at UT Southwestern Medical Center, underscores extensive experience in the industry. Academic credentials include a PhD from Texas A&M University and both an MS and BS from Nanjing University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices